Health

The news of Ugandan Olympic marathon runner Rebecca Cheptegei’s death is truly heartbreaking. Reports indicate that her boyfriend poured gasoline on her and set her on fire, resulting in her untimely demise. This horrific act of violence highlights the urgent need for measures to prevent such tragedies in the future. The recent high school shooting
0 Comments
The study conducted by María Paz Martínez-Vidal, MD, PhD, and colleagues at Hospital Universitario San Juan de Alicante in Spain explores the treatment preferences of Spanish patients with inflammatory arthritis who were prescribed etanercept or adalimumab, comparing their continuation rates with originator products versus biosimilar versions. The findings suggest that patients were more likely to
0 Comments
Patients with atrial fibrillation (Afib) and stable coronary artery disease (CAD) have seen positive results with edoxaban (Savaysa) monotherapy, according to the EPIC-CAD trial. The study revealed that a 12-month composite of death, myocardial infarction, stroke, embolism, urgent revascularization, or bleeding events occurred less frequently in patients on edoxaban monotherapy compared to those on dual
0 Comments
A recent randomized clinical trial conducted by Dr. Benjamin O’Brien, MD, PhD, at Charité Universitätsmedizin Berlin, has shed light on the ineffectiveness of keeping potassium levels high after cardiac surgery in preventing post-surgical atrial fibrillation (Afib). Contrary to common practice, the study found that there was no significant difference in the occurrence of new-onset Afib
0 Comments
A recent cohort study found that first-line antidepressants may have a protective effect against falls and related injuries in older adults. The study, which included over 100,000 Medicare beneficiaries with newly diagnosed depression, showed that the use of certain antidepressants was associated with a decreased risk of falls compared to no treatment. This has significant
0 Comments